Emily Oswald

Nurse Practitioner clinician in Daytona Beach, Florida — also lists obesity medicine in the CMS registry.

Practice Details

Address
311 N Clyde Morris Blvd Ste 500
Daytona Beach, FL 32114
Geocoded location: 29.1998, -81.0548
Taxonomy
Nurse Practitioner, Family
Credential
APRN
NPPES Enumeration
Listed with NPPES since 2022
Sole Proprietor
Yes
Provider Gender (NPPES)
Female
NPPES Record Updated
December 2025

Specialty taxonomies on file (3)

  • Nurse Practitioner
  • Bariatric Surgery
    Surgery, Plastic and Reconstructive Surgery
  • Nurse Practitioner
    Nurse Practitioner, Family
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

Emily Oswald is a Nurse Practitioner clinician in Daytona Beach whose NPPES record also lists an obesity-medicine or bariatric-medicine taxonomy as a secondary specialty. Primary-care and family-medicine clinicians who carry this secondary designation are among those most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices — call ahead to confirm.

Locally, this is 1 of 142 Nurse Practitioner, Family practices in Daytona Beach carrying this exact taxonomy in our directory.

What to expect at a Nurse Practitioner visit

Nurse practitioners provide primary and specialty care and, depending on state scope-of-practice rules, prescribe independently or in collaboration with a physician. A GLP-1-related visit often includes:

  • A health and medication history and goal-setting conversation.
  • Screening labs where indicated before starting therapy.
  • A discussion of GLP-1 options for diabetes or weight management.
  • Follow-up to monitor response and adjust dose.

This is general guidance for nurse practitioner practices, not a description of Emily Oswald's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 386-425-2639.

GLP-1 access in Daytona Beach, Florida

Adult obesity rate
30.1%
#33 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$189/mo
Typical Florida telehealth cash price
Medicaid GLP-1 coverage
Diabetes only
Florida Medicaid, obesity indication

About 30.1% of Florida adults have obesity (BMI 30+), ranking the state #33 of 50 (CDC BRFSS). Our directory currently lists 17 GLP-1-relevant clinics in Daytona Beach. If a cash-pay route makes more sense, compounded semaglutide through Florida telehealth averages about $189/mo — well below brand-name Wegovy or Zepbound.

Explore more Florida options on the best Florida GLP-1 providers page, browse every Daytona Beach listing in the Daytona Beach clinic directory, or read the Florida Medicaid GLP-1 coverage & prior-authorization guide.

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Florida addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Florida telehealth partners:

Featured Partners · Daytona Beach

Featured GLP-1 providers serving Daytona Beach

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →

See more Daytona Beach options on the Daytona Beach clinic directory, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Daytona Beach obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Emily Oswald's specialty taxonomy but not the specific medications it prescribes or its current service menu. Emily Oswald is listed under Nurse Practitioner, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 386-425-2639 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Emily Oswald's primary specialty on file is Nurse Practitioner, with obesity medicine listed as a secondary taxonomy. Generalist clinicians who carry that secondary designation are among those who commonly manage GLP-1 prescribing, though the registry does not confirm current services.
Emily Oswald is located at 311 N Clyde Morris Blvd Ste 500, Daytona Beach, FL 32114. The phone number listed in the registry is 386-425-2639. Its full record is public in the CMS National Provider registry under NPI 1134847940.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Emily Oswald is currently accepting new patients. Call the practice at 386-425-2639 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.